NLTX

Neoleukin Therapeutics

Halal Rating :
Uncomfortable
See Details
Last Price $3.47 Last updated:
Market Cap -
7D Change -0.72%
1 Year Change 60.23%

Company Overview

Industries
  • Health Technology
  • Biotechnology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing
Exchange
Next Earnings Date Nov. 13, 2023

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2023 $1.04m $10.52m $1.04m - 100.00% 0.00%
June 30, 2023 $1.18m $7.54m $981000.0 $981000.0 83.07% 13.01%
March 31, 2023 $755000.0 $25.48m $945000.0 $931000.0 125.17% 3.65%

Company Impact

Help us evaluate Neoleukin Therapeutics's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates